News and Press

Sign up now for the latest IR news, and updates on ongoing developments at Avicanna Inc:

Avicanna Reports First Quarter 2020 Financial Results and Provides Corporate Update
Avicanna Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with World-Class Canadian Manufacturer MediPharm Labs
Avicanna Receives Government Support and Approval for First Ever Export of Hemp Seeds From Colombia
Avicanna Closes Non-Brokered Private Placement with Group of Strategic Investors and Announces Warrant Re-Pricing
Avicanna Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update
Avicanna to Supply Australian Market with Cannabis-Based Medicinal Products Through Distribution Agreement with Cannvalate
Avicanna Ranks Highest Amongst Global Cannabis Companies in the SAM Corporate Sustainability Assessment (CSA)
Avicanna Closes First Tranche of Private Placement
Avicanna Announces Appointment of Benjamin Leavenworth as Independent Director
Avicanna Announces the Successful Completion of its Clinical Study Evaluating the Effect of an Emollient Cream Containing 0.5% Cannabidiol on Skin Hydration
Avicanna Announces Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc., to Distribute Avicanna’s Advanced and Evidence-based Medical Cannabis and Derma-Cosmetic Products Across Canada
Avicanna Enters Into USD$5 Million Revolving Credit Facility